Elastin degradation products in acute lung injury induced by gastric contents aspiration

Respiratory Research
Pedro AyalaGisella R Borzone

Abstract

Gastric contents aspiration is a high-risk condition for acute lung injury (ALI). Consequences range from subclinical pneumonitis to respiratory failure, depending on the volume of aspirate. A large increment in inflammatory cells, an important source of elastase, potentially capable of damaging lung tissue, has been described in experimental models of aspiration. We hypothesized that in early stages of aspiration-induced ALI, there is proteolytic degradation of elastin, preceding collagen deposition. Our aim was to evaluate whether after a single orotracheal instillation of gastric fluid, there is evidence of elastin degradation. Anesthesized Sprague-Dawley rats received a single orotracheal instillation of gastric fluid and were euthanized 4, 12 and 24 h and at day 4 after instillation (n = 6/group). We used immunodetection of soluble elastin in lung tissue and BALF and correlated BALF levels of elastin degradation products with markers of ALI. We investigated possible factors involved in elastin degradation and evaluated whether a similar pattern of elastin degradation can be found in BALF samples of patients with interstitial lung diseases known to have aspirated. Non-parametric ANOVA (Kruskall-Wallis) and linear regression...Continue Reading

References

Jul 1, 1987·Chest·E J CampbellH G Welgus
Jan 15, 1981·Biochimica Et Biophysica Acta·J F Collins, R Fine
Oct 1, 1980·The Journal of Clinical Investigation·R M SeniorR P Mecham
Nov 10, 1998·Archives of Dermatological Research·A HayashiS Tajima
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·G BorzoneC Lisboa
Oct 6, 2001·American Journal of Respiratory and Critical Care Medicine·P R RoccoW A Zin
Sep 17, 2004·Experimental Lung Research·Paul R KnightBruce A Holm
Mar 11, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Bruce A DavidsonRobert H Notter
Mar 22, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Krishnan RaghavendranPaul R Knight
Jan 10, 2006·The Journal of Thoracic and Cardiovascular Surgery·Matthew G HartwigR Duane Davis
May 16, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Dana E McClintockUNKNOWN National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network
Nov 29, 2007·Respiratory Research·James Z AppelR Duane Davis
Jul 22, 2008·Experimental Biology and Medicine·Tacy E DowningShu S Lin
Apr 10, 2009·The European Respiratory Journal·G DesleeR A Pierce
Sep 17, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Takashi AkimaToshiaki Kawai
Aug 1, 1946·American Journal of Obstetrics and Gynecology·C L MENDELSON
Jan 26, 2011·Critical Care Medicine·Krishnan RaghavendranPaul R Knight
May 3, 2011·American Journal of Respiratory Cell and Molecular Biology·Gustavo Matute-BelloUNKNOWN Acute Lung Injury in Animals Study Group
Oct 19, 2011·The European Respiratory Journal·Brijesh V PatelMasao Takata
Jun 8, 2012·Methods in Molecular Biology·Marta TothRafael Fridman
Jun 21, 2014·Annals of the American Thoracic Society·John J CardasisAliya N Husain
Mar 4, 2015·Chest·Xiaowen HuJay H Ryu
Sep 1, 2015·The American Journal of Pathology·Joaquín D AraosGisella R Borzone
Apr 26, 2016·American Journal of Respiratory and Critical Care Medicine·Yohannes T Ghebre, Ganesh Raghu
Sep 2, 2016·The Journal of Clinical Investigation·Amit Gaggar, Nathaniel Weathington
Jan 15, 2018·Matrix Biology : Journal of the International Society for Matrix Biology·Robert P Mecham
May 1, 2018·American Journal of Respiratory Cell and Molecular Biology·Jorge Blázquez-PrietoGuillermo M Albaiceta

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage
electrophoresis
Light

Software Mentioned

ImageJ

Related Concepts

Related Feeds

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.